Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-000279-40Phase 3Active
Phase 3, randomised trial of peginterferon alfa-2b and ribavirin in hepatitis C virus infection (2 arms), sponsored by ASL 2 Savonese. Primary endpoints: Sustained virologic response rate, Quality of life and 1 more. Started Mar 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-000279-40.